Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Date of authorisation: 19/07/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Date of authorisation: 19/07/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

European Shortages Monitoring Platform (ESMP) open Application Programming Interface (API) specifications for the ESMP API for national competent authorities (NCAs) (JSON) (YAML)

European Shortages Monitoring Platform (ESMP) open Application Programming Interface (API) specifications for the ESMP API for national competent authorities (NCAs) (JSON) (YAML)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness